Organization | Fuzhou Infectious Hospital

Fuzhou Infectious Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2018

NCT03577938

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Fuzhou Infectious Hospital

Active Ingredients

Drugs in Other Trials (7)

artemisiacapillaris thunb (1 trial)

gardenia jasminoides ellis (1 trial)

paeoniae radix (1 trial)

rhizoma atractylodis macrocephalae (1 trial)

rubia cordifolia (1 trial)

salvia miltiorrhiza extract (1 trial)

sieyesbeckiaorientalis (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 1
# of Trial APIs: 7